Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

New protocol prevents heavy alcohol relapse after liver transplantation

3

Jun 2026

New protocol prevents heavy alcohol relapse after liver transplantation

In a study published in the Liver Transplantation journal by the American Association for the Study of Liver Diseases, Mayo Clinic researchers found that a new proactive treatment protocol for alcohol use disorder after liver transplant resulted in a 0% heavy alcohol relapse rate among patients who followed the protocol, compared with a historical relapse rate of approximately 25%.

Study links rural living to worse epilepsy health outcomes

3

Jun 2026

Study links rural living to worse epilepsy health outcomes

For people with epilepsy, living in counties that are more rural was associated with poorer health outcomes than for people living in more urban counties, according to a study published June 3, 2026, in Neurology, the medical journal of the American Academy of Neurology.

Constipation may be tied to more than discomfort

3

Jun 2026

Constipation may be tied to more than discomfort

Constipation was associated with approximately twofold higher odds of depression in a meta-analysis of 18 observational studies involving 730,263 participants. The findings support integrated gastrointestinal and mental health assessment, especially for adolescents and young adults, while emphasizing that causality cannot yet be established.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.